NCT04146935View on ClinicalTrials.gov

Examining the Effect of Burosumab on Muscle Function

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 13, 2019

Primary Completion Date

August 25, 2022

Study Completion Date

August 25, 2022

Conditions
X-linked Hypophosphatemia
Interventions
DRUG

Burosumab Injection [Crysvita]

Burosumab/Crysvita SC injection monthly

Trial Locations (1)

06520

Yale University School of Medicine, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT04146935 - Examining the Effect of Burosumab on Muscle Function | Biotech Hunter | Biotech Hunter